Physician

William Scott Grover, MD

According to 2025 Medicare claims, William Grover, MD (NPI: 1598023228) practices ophthalmology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is CHARLOTTESVILLE EYE ASSOCIATES LTD (NPI: 1548200280; TIN: 54-1056576) and primary practice location at 22901-8318.

Grover's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,440 traditional Medicare patients, billed 3,563 HCPCS/CPT codes, and received $522,669 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 2,308 prescription claims across 731 beneficiaries totaling $244,483 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). DME data shows 87 claims. Open Payments data shows 13 records totaling $313. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,340 to $522,669. Similarly, Part D prescription costs have risen steadily, from $22,602 to $244,483. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	45	51	$5,340
2017	298	528	$65,524
2018	622	1,688	$287,420
2019	1,035	2,643	$440,069
2020	1,206	2,852	$420,208
2021	1,475	3,357	$476,038
2022	1,463	3,600	$527,283
2023	1,494	3,532	$468,965
2024	1,440	3,563	$522,669

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	104	349	$22,602
2016	126	374	$30,217
2017	192	465	$60,409
2018	246	609	$64,636
2019	384	1,259	$185,685
2020	389	1,170	$59,725
2021	419	1,279	$53,724
2022	570	1,883	$71,187
2023	665	2,114	$79,882
2024	731	2,308	$244,483

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	20	20	$1,523
2019	57	57	$3,915
2020	55	55	$3,610
2021	83	83	$4,799
2022	88	90	$6,193
2023	100	100	$6,980
2024	87	87	$6,846

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	375	633	$410
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	311	311	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	306	332	$84
92014	Established patient complete exam of visual system	495	499	$81
92136	Measurement of corneal curvature and depth of eye	412	670	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	999	27,840	$27,247
Ciprofloxacin Hcl	Ciprofloxacin Hcl	692	14,457	$7,119
Difluprednate	Difluprednate	56	1,380	$5,616
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	70	5,026	$2,206
Loteprednol Etabonate	Loteprednol Etabonate	14	606	$1,736

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	40	40	$4,297
V2020	Frames, purchases	N	34	34	$1,697
V2103	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	13	13	$852

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$313	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William Scott Grover, MD?

Tedicare shows public-source Medicare data for William Scott Grover, MD (NPI 1598023228), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William Scott Grover, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to William Scott Grover, MD?

William Scott Grover, MD is linked to CHARLOTTESVILLE EYE ASSOCIATES LTD (billing NPI 1548200280) in the available physician profile data.

Does William Scott Grover, MD have Open Payments data?

William Scott Grover, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.